Original language | English |
---|---|
Pages (from-to) | 97-104 |
Number of pages | 8 |
Journal | Int J Hematol |
Volume | 70 |
Issue number | (2) |
Publication status | Published - 1999 |
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group.
Mitsune Tanimoto
Research output: Contribution to journal › Article